Jackson Financial (JXN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Apr, 2026Executive summary
Annual meeting scheduled for May 21, 2026, at 9:30 A.M. EDT in Lansing, Michigan.
Shareholders are invited to vote on key proposals, with materials available online or by request.
Voting matters and shareholder proposals
Election of nine directors is on the agenda, with individual nominees listed.
Advisory vote on executive compensation is included.
Ratification of KPMG LLP as independent auditor for 2026 is proposed.
Board recommends voting in favor of all proposals.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Nominees for director positions include Lily Fu Claffee, Gregory T. Durant, Steven A. Kandarian, Derek G. Kirkland, Drew E. Lawton, Martin J. Lippert, Russell G. Noles, Laura L. Prieskorn, and Esta E. Stecher.
Latest events from Jackson Financial
- Record annuity sales, strong capital returns, and 2026 guidance for higher shareholder payouts.JXN
Q4 20259 Jul 2026 - TPG partnership and Hickory Re launch drive growth, capital efficiency, and profitability.JXN
Partnership8 Jul 2026 - Adjusted earnings up 13%, annuity sales and capital returns strong despite net loss.JXN
Q1 20258 Jul 2026 - FABN program is well-capitalized, diversified, and supported by strong risk management.JXN
Investor presentation4 Jun 2026 - Strong sales, capital returns, and RILA growth position the firm for sustainable expansion.JXN
Investor presentation8 May 2026 - Retail annuity sales rose 31% and $257M was returned to shareholders despite a $435M net loss.JXN
Q1 20266 May 2026 - Exceeded 2025 targets, boosted capital returns, and advanced governance and ESG priorities.JXN
Proxy filing7 Apr 2026 - Q2 2024 saw adjusted operating earnings up 45% and record RILA sales with strong capital returns.JXN
Q2 20242 Feb 2026 - Retail annuity sales hit record highs, but net income turned negative on reinsurance losses.JXN
Q3 202415 Jan 2026